Security key
71880W501
Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO)
CUSIP: 71880W501
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 188,486
- Total 13F value
- $467,442
- Share change
- +23,351
- SEC-reported price per share
- $2.48
- Number of holders
- 11
- Value change
- +$59,965
- Number of buys
- 6
- Number of sells
- 4
- Shares outstanding
- 12,067,869
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
11
Top holders
10
PHIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Phio Pharmaceuticals Corp. SEC filings
Phio Pharmaceuticals Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71880W501
Recent filing periods:
Ownership snapshot
Top reported holders of PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Robert L. Ferrara
Disclosed value leader
Gerrit Dispersyn
Comparable rows
12/15
Latest evidence
11 Sep 2025
3/4/5
13F
Lead comparable stake: 0.32%
3 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Robert L. Ferrara leads the comparable SEC ownership view at 0.32%.
12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Robert L. Ferrara's linked filing trail.
Comparable ownership
Top 5
Robert L. Ferrara
0.32%
GEODE CAPITAL MANAGEMENT, LLC
0.48%
VANGUARD GROUP INC
0.4%
Cetera Investment Advisers
0.27%
Virtu Financial LLC
0.12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Robert L. Ferrara |
3/4/5
Director
|
0.32%
|
$82,959
38,766 shares
|
— | 11 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.48%
|
$135,580
57,694 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.4%
|
$114,363
48,665 shares
|
— | 30 Jun 2025 |
| Cetera Investment Advisers |
13F
Company
|
0.27%
|
$76,375
32,500 shares
|
— | 30 Jun 2025 |
| Virtu Financial LLC |
13F
Company
|
0.12%
|
$34,000
14,298 shares
|
— | 30 Jun 2025 |
| MORGAN STANLEY |
13F
Company
|
0.05%
|
$14,100
6,000 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
188,486
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
11
Q3 2025 holders
11
Holder diff
0
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend